Premium
PET‐CR AS A SURROGATE FOR SURVIVAL OUTCOMES IN DLBCL: A LITERATURE BASED META‐ANALYSIS
Author(s) -
Berry D.A.,
Broglio K.R.,
Ward C.,
Sahin D.,
Nielsen T.,
Mattiello F.,
McGlothlin A.E.,
Wendelberger B.A.,
Foster M.,
Nowakowski G.S.,
Kostakoglu L.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.59_2630
Subject(s) - hazard ratio , medicine , surrogate endpoint , oncology , progression free survival , clinical endpoint , confidence interval , meta analysis , clinical trial , diffuse large b cell lymphoma , proportional hazards model , survival analysis , overall survival , lymphoma